XML 51 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 10 - Stockholders' Equity
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
Note
10:
Stockholders’ Equity
 
Common Stock
 
We are authorized to issue
750,000,000
shares of common stock,
$0.25
par value per share, of which
487,830,728
shares of common stock were issued and
5,226,791
shares issued and held in treasury, for a net of
482,603,937
shares outstanding as of
December 
31,
2018.
All of our currently outstanding shares of common stock are listed on the New York Stock Exchange under the symbol “HL.”
 
Subject to the rights of the holders of any outstanding shares of preferred stock, each share of common stock is entitled to: (i)
one
vote on all matters presented to the stockholders, with
no
cumulative voting rights; (ii) receive such dividends as
may
be declared by the board of directors out of funds legally available therefor; and (iii) in the event of our liquidation or dissolution, share ratably in any distribution of our assets.
 
Dividends
 
In
September 2011
and
February 2012,
our board of directors adopted a common stock dividend policy that has
two
components: (
1
) a dividend that links the amount of dividends on our common stock to our average quarterly realized silver price in the preceding quarter, and (
2
) a minimum annual dividend of
$0.01
per share of common stock, in each case, payable quarterly, if and when declared. For illustrative purposes only, the table below summarizes potential per share dividend amounts at different quarterly average realized price levels according to the
first
component of the policy:
 
Quarterly average
realized silver price
per ounce
   
Quarterly dividend
per share
   
Annual dividend
per share
 
$30    
$0.01
   
$0.04
 
$35    
$0.02
   
$0.08
 
$40    
$0.03
   
$0.12
 
$45    
$0.04
   
$0.16
 
$50    
$0.05
   
$0.20
 
$55    
$0.06
   
$0.24
 
$60    
$0.07
   
$0.28
 
 
The following table summarizes the quarterly common stock dividends declared by our board of directors for the years ended
December 31, 2016,
2017
and
2018:
 
   
(A)
   
(B)
   
(A+B)
   
 
 
 
Declaration date
 
Silver-price-
linked
component
per share
   
Minimum
annual
component
per share
   
Total
dividend
per share
   
Total dividend
amount (in
millions)
 
Month of
payment
February 20, 2016
 
$—
   
$0.0025
   
$0.0025
   
$0.9
 
March 2016
May 4, 2016
 
$—
   
$0.0025
   
$0.0025
   
$1.0
 
June 2016
August 3, 2016
 
$—
   
$0.0025
   
$0.0025
   
$1.0
 
September 2016
November 4, 2016
 
$—
   
$0.0025
   
$0.0025
   
$1.0
 
December 2016
February 21, 2017
 
$—
   
$0.0025
   
$0.0025
   
$1.0
 
March 2017
May 4, 2017
 
$—
   
$0.0025
   
$0.0025
   
$1.0
 
June 2017
August 3, 2017
 
$—
   
$0.0025
   
$0.0025
   
$1.0
 
September 2017
November 7, 2017
 
$—
   
$0.0025
   
$0.0025
   
$1.0
 
December 2017
February 14, 2018
 
$—
   
$0.0025
   
$0.0025
   
$1.0
 
March 2018
May 9, 2018
 
$—
   
$0.0025
   
$0.0025
   
$1.0
 
June 2018
August 8, 2018
 
$—
   
$0.0025
   
$0.0025
   
$1.2
 
September 2018
November 6, 2018
 
$—
   
$0.0025
   
$0.0025
   
$1.2
 
December 2018
February 20, 2019
 
$—
   
$0.0025
   
$0.0025
   
$1.2
 
March 2019
 
Because the average realized silver prices for all periods in
2016,
2017
and
2018
were below the minimum threshold of
$30,
according to the policy
no
silver-price-linked component was declared or paid. Prior to
2011,
no
dividends had been declared on our common stock since
1990.
The declaration and payment of common stock dividends is at the sole discretion of our board of directors.
 
At-The-Market Equity Distribution Agreement
 
Pursuant to an equity distribution agreement dated
February 23, 2016,
as amended, we
may
issue and sell from time to time through ordinary broker transactions shares of our common stock having an aggregate offering price of up to
$75
million, with the net proceeds available for general corporate purposes. The terms of sales transactions under the agreement, including trading day(s), number of shares sold in the aggregate, number of shares sold per trading day, and the floor selling price per share, are proposed by us to the sales agent. Whether or
not
we engage in sales from time to time
may
depend on a variety of factors, including share price, our cash resources, customary black-out restrictions, and whether we have any material inside information. The agreement can be terminated by us at any time. The shares issued under the equity distribution agreement are registered under the Securities Act of
1933,
as amended, pursuant to our shelf registration statement on Form S-
3,
which was filed with the SEC on
February 23, 2016 (
which we expect to replace with a new shelf registration statement on Form S-
3
in late
February 2019).
As of
December 
31,
2018,
we had sold
7,173,614
shares under the agreement for proceeds of approximately
$24.5
million, net of commissions of approximately
$0.6
million. We sold
2,564,767
shares under the agreement in
2018
for total proceeds of
$6.7
million, net of commissions of approximately
$0.1
million.
 
Common Stock Repurchase Program
 
On
May 8, 2012,
we announced that our board of directors approved a stock repurchase program.  Under the program, we are authorized to repurchase up to
20
million shares of our outstanding common stock from time to time in open market or privately negotiated transactions, depending on prevailing market conditions and other factors. The repurchase program
may
be modified, suspended or discontinued by us at any time. As of
December 
31,
2018,
934,100
shares have been repurchased under the program, at an average price of
$3.99
per share, leaving approximately
19.1
million shares that
may
yet be purchased under the program. The closing price of our common stock at
February 19, 2019,
was
$2.92
per share.
 
Preferred Stock
 
Our certificate of incorporation authorizes us to issue
5,000,000
shares of preferred stock, par value
$0.25
per share. The preferred stock is issuable in series with such voting rights, if any, designations, powers, preferences and other rights and such qualifications, limitations and restrictions as
may
be determined by our board of directors. The board
may
fix the number of shares constituting each series and increase or decrease the number of shares of any series. As of
December 
31,
2018,
157,816
shares of Series B preferred stock were outstanding. Our Series B preferred stock is listed on the New York Stock Exchange under the symbol “HL PB.”
 
Ranking
 
The Series B preferred stock ranks senior to our common stock and any shares of Series A junior participating preferred stock (
none
of which have ever been issued) with respect to payment of dividends, and amounts due upon liquidation, dissolution or winding up.
 
While any shares of Series B preferred stock are outstanding, we
may
not
authorize the creation or issuance of any class or series of stock that ranks senior to the Series B preferred stock as to dividends or amounts due upon liquidation, dissolution or winding up without the consent of the holders of
66
2/3%
of the outstanding shares of Series B preferred stock and any other series of preferred stock ranking on a parity with the Series B preferred stock as to dividends and amounts due upon liquidation, dissolution or winding up, voting as a single class without regard to series.
 
Dividends
 
Series B preferred stockholders are entitled to receive, when, as and if declared by the board of directors out of our assets legally available therefor, cumulative cash dividends at the rate per annum of
$3.50
per share of Series B preferred stock. Dividends on the Series B preferred stock are payable quarterly in arrears on
October 
1,
January 
1,
April 1
and
July 1
of each year (and, in the case of any undeclared and unpaid dividends, at such additional times and for such interim periods, if any, as determined by the board of directors), at such annual rate. Dividends are cumulative from the date of the original issuance of the Series B preferred stock, whether or
not
in any dividend period or periods we have assets legally available for the payment of such dividends. Accumulations of dividends on shares of Series B preferred stock do
not
bear interest.
 
All quarterly dividends on our Series B preferred stock for
2016,
2017
and
2018
were declared and paid in cash.
 
Redemption
 
The Series B preferred stock is redeemable at our option, in whole or in part, at
$50
per share, plus all dividends undeclared and unpaid on the Series B preferred stock up to the date fixed for redemption.
 
Liquidation Preference
 
The Series B preferred stockholders are entitled to receive, in the event that we are liquidated, dissolved or wound up, whether voluntary or involuntary,
$50
per share of Series B preferred stock plus an amount per share equal to all dividends undeclared and unpaid thereon to the date of final distribution to such holders (the “Liquidation Preference”), and
no
more. Until the Series B preferred stockholders have been paid the Liquidation Preference in full,
no
payment will be made to any holder of Junior Stock upon our liquidation, dissolution or winding up. The term “junior stock” means our common stock and any other class of our capital stock issued and outstanding that ranks junior as to the payment of dividends or amounts payable upon liquidation, dissolution and winding up to the Series B preferred stock. As of
December 
31,
2018
and
2017,
our Series B preferred stock had a Liquidation Preference of
$7.9
million.
 
 
Voting Rights
 
Except in certain circumstances and as otherwise from time to time required by applicable law, the Series B preferred stockholders have
no
voting rights and their consent is
not
required for taking any corporate action. When and if the Series B preferred stockholders are entitled to vote, each holder will be entitled to
one
vote per share.
 
Conversion
 
Each share of Series B preferred stock is convertible, in whole or in part at the option of the holders thereof, into shares of common stock at a conversion price of
$15.55
per share of common stock (equivalent to a conversion rate of
3.2154
shares of common stock for each share of Series B preferred stock). The right to convert shares of Series B preferred stock called for redemption will terminate at the close of business on the day preceding a redemption date (unless we default in payment of the redemption price).
 
Stock Award Plans
 
We use stock-based compensation plans to aid us in attracting, retaining and motivating our employees, as well as to provide incentives more directly linked to increases in stockholder value. These plans provide for the grant of options to purchase shares of our common stock, the issuance of restricted stock units, and other equity-based awards.
 
Stock-based compensation expense amounts recognized for the years ended
December 
31,
2018,
2017
and
2016
were approximately
$6.3
million,
$6.3
million, and
$6.2
million, respectively.  Over the next
twelve
months, we expect to recognize approximately
$4.5
million in additional compensation expense as outstanding restricted stock units and performance-based shares vest.
 
Stock Incentive Plan
 
 During the
second
quarter of
2010,
our stockholders voted to approve the adoption of our
2010
Stock Incentive Plan and to reserve up to
20,000,000
shares of common stock for issuance under the plan.  The board of directors has broad authority under the
2010
plan to fix the terms and conditions of individual agreements with participants, including the duration of the award and any vesting requirements. As of
December 
31,
2018,
there were
3,267,759
shares available for future grant under the
2010
plan.
 
Directors’ Stock Plan
 
In
2017,
we adopted the amended and restated Hecla Mining Company Stock Plan for Non-Employee Directors (the “Directors’ Stock Plan”), which
may
be terminated by our board of directors at any time. Each non-employee director is credited each year with that number of shares determined by dividing
$120,000
by the average closing price for our common stock on the New York Stock Exchange for the prior calendar year. A minimum of
25%
of the shares credited each year is held in trust for the benefit of each director until delivered to the director. Each director
may
elect, prior to the
first
day of the applicable year, to have a greater percentage contributed to the trust for that year. Delivery of the shares from the trust occurs upon the earliest of: (
1
) death or disability; (
2
) retirement; (
3
) a cessation of the director’s service for any other reason; (
4
) a change in control; or (
5
) at the election of the director at any time, provided, however, that shares must be held in the trust for at least
two
years prior to delivery. During
2018,
2017,
and
2016,
161,630,
156,122,
and
68,462
shares, respectively, were credited to the non-employee directors. During
2018,
2017
and
2016,
$593,000,
$774,000,
and
$271,000,
respectively, was charged to general and administrative expense associated with the shares issued to the non-employee directors. At
December 
31,
2018,
there were
3,120,707
shares available for grant in the future under the plan.
 
In addition to the foregoing, for
2016,
120,911
shares were credited to the non-employee directors, and
$532,000
was charged to general and administrative expense, associated with the
2010
Stock Incentive Plan.
 
Restricted Stock Units
 
Unvested restricted stock units granted by the board of directors to employees are summarized as follows:
 
   
Shares
   
Weighted Average
Grant Date Fair
Value per Share
 
Unvested, January 1, 2018
   
2,095,318
    $
4.52
 
Granted (unvested)
   
1,975,662
    $
3.53
 
Canceled
   
(196,594
)
  $
3.48
 
Distributed (vested)
   
(1,184,918
)
  $
3.91
 
Unvested, December 31, 2018
   
2,689,468
    $
4.14
 
 
The
2,689,468
unvested units at
December 
31,
2018
are scheduled to vest as follows:
 
1,246,291  
in June 2019
866,680  
in June 2020
576,497  
in June 2021
 
Unvested units will be forfeited by participants through termination of employment in advance of vesting, with the exception of termination due to retirement if certain criteria are met. Since the earliest grant date of unvested units (which was
2016
), we have recognized approximately
$5.2
million in compensation expense, including approximately
$3.8
million recognized in
2018,
and expect to record an additional
$5.9
million in compensation expense over the remaining vesting period related to these units. The latest vesting date for unvested units as of
December 
31,
2018
is
June 2021.
 
Performance-Based Shares
 
We periodically grant performance-based share awards to certain executive employees. The value of the awards is based on the ranking of the market performance of our common stock relative to the performance of the common stock of a group of peer companies over a
three
-year measurement period. The number of shares to be issued is based on the value of the awards divided by the share price at grant date. The compensation cost is measured using a Monte Carlo simulation to estimate their value at grant date. Since the earliest grant date of unvested units (which was
2017
), we have recognized approximately
$0.5
million in compensation expense, including approximately
$0.4
million recognized in
2018,
and expect to record an additional
$0.9
million in compensation expense over the remaining vesting period related to these awards. The latest vesting date for unvested units as of
December 
31,
2018
is
December 31, 2020.
 
In connection with the vesting of restricted stock units, performance-based shares and other stock grants, employees have in the past, at their election and when permitted by us, chosen to satisfy their tax withholding obligations through net share settlement, pursuant to which we withhold the number of shares necessary to satisfy such withholding obligations and pay the obligations in cash.  Pursuant to such net settlements, in
2018
we withheld
697,341
shares valued at approximately
$2.7
million, or approximately
$3.86
per share.  In
2017,
we withheld
588,240
shares valued at approximately
$2.9
million, or approximately
$4.88
per share. These shares become treasury shares unless we cancel them.
 
Warrants
 
As discussed in
Note
16
, we issued
4,136,000
warrants to purchase
one
share of our common stock to holders of warrants to purchase Klondex common stock under the terms of the Klondex acquisition, and all of the warrants were outstanding as of
December 
31,
2018.
2,068,000
of the warrants have an exercise price of
$8.02
and expire in
April 2032.
2,068,000
of the warrants have an exercise price of
$1.57
and expire in
February 2029.